HDAC9 and cancer: We demonstrated that the metabolic properties of stem-like cancer cells induced via HDAC inhibition differ from more differentiated cancer cells and that HDAC inhibitor-induced dedifferentiation promotes reprogramming into the pentose phosphate pathway metabolism.